AG 55 First Filing Hits: What Life Actuaries Learned

April 1, 2026 was the first filing deadline under Actuarial Guideline LV_1.pdf). U.S. ceding insurers had to submit asset adequacy testing results for offshore reinsurance treaties whose assuming counterparty files no VM-30 memorandum with U.S. regulators. The NAIC puts roughly 100 treaties in scope for the 2025 year-end cycle.

Year one is disclosure only. That framing was a negotiated compromise, and it does not mean the analysis carries no reserve consequence.

Key Takeaways

Roughly 100 treaties fell in scope for year-end 2025, filed by April 1, 2026 into the same deadline that already carries the VM-30 actuarial memorandum.
Four size tiers decide which cessions get full cash flow testing, from any cession above $5 billion down to $100 million at more than 20% of life and annuity reserves.
Disclosure only is not consequence free. The appointed actuary keeps the authority to hold additional reserves on the AG 55 analysis, and the domestic regulator can require them. What was dropped is a prescriptive formula.
$2.4 trillion of reserves were ceded by U.S. life insurers in 2024, more than $1.1 trillion of it offshore, against a Bermuda long-term sector managing $1.52 trillion in assets.
Four months separated adoption on August 13, 2025 from the December 31, 2025 effective date, which is why the hardship extension past April 1 exists.

What the Guideline Actually Reaches

AG 55 closes a specific gap: before it, a ceding company's appointed actuary had no requirement to evaluate reserves held by an offshore reinsurer outside U.S. jurisdiction.

The mechanism is cash flow testing of the post-reinsurance reserve, asking whether the assets supporting ceded business stay adequate under moderately adverse conditions. Results go to the ceding company's domestic regulator annually, either as a clearly separated section of the VM-30 memorandum or as a standalone document.

Scope turns on the treaty date and the relationship. Asset-intensive cessions established on or after January 1, 2016 are covered where the counterparty files no VM-30. For non-affiliated transactions the date shifts to January 1, 2020, with a hardship exemption available for 2016 through 2019 treaties subject to regulator approval. Affiliated transactions, meaning the cedant holds a 1% or greater stake or the reinsurer holds more than 25% of reserves assumed from that cedant, carry the full requirement from 2016.

Within scope, a tiered materiality test decides who gets tested in full:

Ceded Reserve Threshold	Percentage of Life/Annuity Reserves	Requirement
Exceeds $5 billion	Any percentage	Full CFT required
Exceeds $1 billion	More than 5%	Full CFT required
Exceeds $500 million	More than 10%	Full CFT required
Exceeds $100 million	More than 20%	Full CFT required

The appointed actuary can also flag a treaty for counterparty collectability risk regardless of size, which keeps the thresholds from functioning as a safe harbour.

Where the Reserve Consequence Actually Sits

The guideline's analytical weight is carried by two components, and both are built to expose basis risk rather than to compute a required reserve.

The Starting Asset Amount equals the post-reinsurance reserve less guideline-excluded assets: non-admitted assets, letters of credit, parental guarantees. Stripping those out forces the actuary to say what genuinely backs the ceded liabilities once forms of support that may not be available under stress are removed.

The attribution analysis bridges the pre-reinsurance and post-reinsurance reserves and assigns the difference to named drivers: discount rates, policyholder behaviour, mortality, and reserve floor removals. That is where the transparency objective becomes concrete, because it separates reduction that reflects genuine actuarial adjustment from reduction that reflects the gap between U.S. statutory reserving and an offshore framework.

That gap is the point. Bermuda's Economic Balance Sheet, run through Technical Provisions, generally produces lower reserves than U.S. methods on comparable blocks. AG 55 asks whether assets at the reinsurer are adequate under U.S. standards, not Bermuda standards, and reciprocal jurisdiction status does not exempt a cedant from demonstrating it. The reserve consequence follows from the actuary's own conclusion rather than from a formula: nothing in the guideline triggers a reserve automatically, and nothing in it stops the actuary or the regulator from requiring one.

The scale explains the regulatory attention. U.S. life insurers ceded roughly $2.4 trillion of reserves in 2024, more than $1.1 trillion of it offshore, and Bermuda's long-term sector manages $1.52 trillion in assets across more than 80 Class E reinsurers serving approximately 90 million policyholders. The transaction flow through the first filing cycle was heavy: Corebridge and Venerable at roughly $51 billion of account value, Aquarian Capital's $4.1 billion Brighthouse acquisition, MetLife and Talcott at $10 billion of variable annuity reserves, and Equitable's 75% cession of an individual life block to RGA releasing more than $2 billion of deployable capital.

The Proxy Portfolio Is Doing the Work

The weak point is that many cedants cannot see the assets they are being asked to test, and the guideline's answer shifts the analysis onto the cedant's own assumptions.

Offshore arrangements frequently involve commingled asset pools, and treaties written before AG 55 was contemplated often carry no obligation to report asset-level detail to the cedant. Where actual data is unavailable, AG 55 directs the actuary to build a "conservative proxy asset portfolio and assumption set." That prevents opacity from understating the problem. It also means the tested portfolio may be one the actuary constructed rather than one the reinsurer holds.

Both sides have a defensible position. Bermuda reinsurers point to oversight by the Bermuda Monetary Authority, tightened through the CP1 and CP2 enhancements enacted in March 2024, and to the confidentiality and operational cost of supplying asset detail to every cedant. Cedant actuaries need enough data for credible testing and are reluctant to rest a filed conclusion on proxy assumptions that could run in either direction.

The Similar Memorandum alternative is the available bridge: where the assuming reinsurer produces a memorandum comparable to VM-30 and the domestic regulator can use it to determine asset adequacy, it may substitute for independent testing. It has to carry eleven elements, from asset descriptions and methodology through year-over-year changes and qualified actuary standards, so it is not a light document to produce.

Interpretation variance follows directly from all of this. With no precedent in the first cycle, companies made different calls on what counts as conservative, how to define the starting asset amount where support runs through several layers, and how to calibrate moderately adverse conditions for portfolios that look nothing like a U.S. statutory book. The Life Actuarial Task Force issued standardized reporting templates at the Fall 2025 National Meeting covering assuming company details, key risks, supporting assets, assumed net yields, testing results and attribution. A template standardizes the format of a judgment without standardizing the judgment itself, and aggregation by counterparty was permitted for year-end 2025 before product-line testing begins.

AG 55 First Filing Hits: What Life Actuaries Learned

Key Takeaways

What the Guideline Actually Reaches

Where the Reserve Consequence Actually Sits

The Proxy Portfolio Is Doing the Work

Further Reading

Sources